About NJ Bio
NJ Bio is a company based in North Brunswick (United States) founded in 2018 was acquired by Suven Pharmaceuticals in December 2024.. NJ Bio has completed 1 acquisition, including L2P Research Labs. NJ Bio offers products and services including ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and Oligonucleotide Services. NJ Bio operates in a competitive market with competitors including Liberation Labs, Kinaxo Biotechnologies, Shantani Proteome Analytics, Scala Biodesign and Seranova, among others.
- Headquarter North Brunswick, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nj Bio, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Suven Pharmaceuticals
(Dec 07, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NJ Bio
NJ Bio offers a comprehensive portfolio of products and services, including ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and Oligonucleotide Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Specialized services for antibody-drug conjugate design and production
Custom manufacturing of biopharmaceutical compounds and linkers
Processes for linking payloads to antibodies in drug development
Analytical testing for drug efficacy and safety assessments
Synthesis and analysis of oligonucleotides for research needs
Development and production of mRNA-based therapeutic components
Custom synthesis of medicinal compounds for drug discovery
Unlock access to complete
Unlock access to complete
Funding Insights of NJ Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NJ Bio
NJ Bio has secured backing from 1 investor. Prominent investors backing the company include Suven Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract manufacturing and development of APIs and formulations are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NJ Bio
NJ Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include L2P Research Labs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
L2P Research Labs is engaged in clinical and non-clinical research.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - NJ Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nj Bio Comparisons
Competitors of NJ Bio
NJ Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Liberation Labs, Kinaxo Biotechnologies, Shantani Proteome Analytics, Scala Biodesign and Seranova, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Fermentation products are manufactured and commercialized via CRO services.
|
|
| domain | founded_year | HQ Location |
Chemical proteomics for cellular target profiling and drug discovery services
|
|
| domain | founded_year | HQ Location |
Drug discovery services are delivered via chemical-proteomics technologies.
|
|
| domain | founded_year | HQ Location |
Computational protein design solutions are delivered at scale.
|
|
| domain | founded_year | HQ Location |
CRO offering chemical proteomics services for preclinical development of drug
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nj Bio
Frequently Asked Questions about NJ Bio
When was NJ Bio founded?
NJ Bio was founded in 2018.
Where is NJ Bio located?
NJ Bio is headquartered in North Brunswick, United States. It is registered at North Brunswick, New Jersey, United States.
What does NJ Bio do?
NJ Bio was founded in 2018 and is based in North Brunswick, United States. Clinical development services are offered by the company within the biotechnology sector. Operations focus on supporting drug development processes, including trial management and regulatory compliance. Expertise is applied to assist clients in advancing therapeutic candidates from preclinical stages through clinical trials. The firms activities are centered in the U.S., serving pharmaceutical and biotech partners.
Who are the top competitors of NJ Bio?
NJ Bio's top competitors include Liberation Labs, Shantani Proteome Analytics and Kinaxo Biotechnologies.
What products or services does NJ Bio offer?
NJ Bio offers ADC Services, Manufacturing Services, Bioconjugation Services, Bioanalytical Services, and 3 more products and services.
How many acquisitions has NJ Bio made?
NJ Bio has made 1 acquisition, including L2P Research Labs.
Who are NJ Bio's investors?
NJ Bio has 1 investor. Key investors include Suven Pharma.